“…These finding suggested a possible role for chronic hepatitis C in the pathogenesis of NHL and cryoglobulinemia.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis C (HCV), a leading cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma, is the most common indication for liver transplantation in the United States. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Interferon is being increasingly used in the treatment of chronic hepatitis C. Several case reports have suggested an association between interferon therapy and sarcoidosis with hypercalcemia. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The hepatitis C virus (HCV) is both hepatotropic and lymphotropic, responsible for a great number of hepatic and extrahepatic immune-system disorders that comprise the so-called HCV syndrome. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Furthermore, culture models provide a platform in which therapeutic interventions can be devised or monitored. Hepatitis C virus (HCV) has a restricted tropism to human and chimpanzees; thus investigations of HCV biology have been hindered for many years due to a lack of small animal models. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis C virus (HCV) infection is a major cause of chronic liver disease worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Boceprevir was the first agent, along with telaprevir, of a novel class of direct-acting antivirals that entered clinical practice for the treatment of chronic hepatitis C. Boceprevir is an antiprotease that directly blocks hepatitis C virus (HCV) replication. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Two classes of hepatitis C antiviral agents currently exist, ie, direct-acting antivirals and host-targeting antivirals. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Replication of the hepatitis C virus (HCV) is an error-prone process. This high error rate results in the emergence of viral populations (quasispecies) within hosts and contributes to interhost variability. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis C virus (HCV) and human pegivirus (HPgV or GB virus C) are globally distributed and infect 2 to 5% of the human population. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Postmenopausal women with chronic hepatitis C exhibited a poor response to interferon (IFN) therapy compared to premenopausal women. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Since the identification of hepatitis C virus (HCV), viral sequencing has been important in understanding HCV classification, epidemiology, evolution, transmission clustering, treatment response and natural history. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Thus, the treatment of hepatitis C virus infection could be simplified in the near future.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis C virus (HCV) infection is the most common etiology of chronic liver disease in Western countries. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND/AIMS: The aim of this study is to investigate the rate of sustained virologic response (SVR) in chronic hepatitis C patients receiving antiviral treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This descriptive qualitative study examined the patient, provider, and institutional factors contributing to nonattendance for hepatitis C (HCV) care throughout the disease course. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso